News | Health & Safety
18 Mar 2018 18:45
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.

    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    © 2018 NZN, NZCity

     Other Health & Safety News
     17 Mar: Surgical mesh reform a failure, advocates
     16 Mar: Mums-to-be upsold expensive multivitamins
     14 Mar: Bad batch of drugs taken was not ecstasy
     14 Mar: Plain cigarette packaging hits shelves
     13 Mar: Second measles case in Auckland
     12 Mar: Faithful dog waits outside Brazilian hospital four months after his homeless owner dies
     11 Mar: Meningococcal case prompts warning
     Top Stories

    Squire out for six weeks with injury More...

    Maori collective eye berries to boost jobs More...

     Today's News

    Greens hand National Parliament questions 17:55

    Ocean Race yachts leave Auckland 17:55

    Accident and Emergency:
    Yacht rescue attempts remain unsuccessful 17:25

    Why Japan's smoking laws are stuck 'in the last century' 16:45

    Evans fourth in Formula E Uruguary race 16:15

    Squire out for six weeks with injury 15:25

    Henare quits as Breakers coach 14:55

    Law and Order:
    Sam Burgess charged for cannonball tackle 14:05

    Reds win in Argentina for three in a row 13:45

    Melbourne double-ton a boost for Cook 13:45

     News Search

    Power Search

    © 2018 New Zealand City Ltd